These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 24153415)
21. [The smoking gun of cardiovascular diseases? The great interest in Lp(a)-lipoprotein]. Dahlén GH Lakartidningen; 1993 Jan; 90(4):259-62. PubMed ID: 8433604 [TBL] [Abstract][Full Text] [Related]
22. Lipoprotein(a) risk in women and efficacy of ascorbate. Bostom AG JAMA; 1994 Oct; 272(15):1169. PubMed ID: 7933344 [No Abstract] [Full Text] [Related]
23. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management. Keller C Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568 [TBL] [Abstract][Full Text] [Related]
24. [Lp(a) and the cardiovascular risk in dyslipidemia subjects]. Arsenio L; Cioni F; Japichino GG; Strata A Acta Biomed Ateneo Parmense; 1998; 69(3-4):97-103. PubMed ID: 10503069 [TBL] [Abstract][Full Text] [Related]
25. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes]. Głowińska B; Urban M; Koput A Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245 [TBL] [Abstract][Full Text] [Related]
26. Is lipoprotein(a) cholesterol a significant indicator of cardiovascular risk? Nauck M; März W; Wieland H Clin Chem; 2000 Mar; 46(3):436-7. PubMed ID: 10702541 [No Abstract] [Full Text] [Related]
27. Lipoprotein(a) identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort Study. Cunningham TE; Sayers SM; Singh GR J Paediatr Child Health; 2011 May; 47(5):257-61. PubMed ID: 21244559 [TBL] [Abstract][Full Text] [Related]
29. [Lipoprotein(a): from hidden pre-beta lipoprotein to cardiovascular risk factor]. Lasunción MA; Alvarez JJ; Herrera E Med Clin (Barc); 1993 Oct; 101(11):424-30. PubMed ID: 8231359 [No Abstract] [Full Text] [Related]
30. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis]. Kullich W; Machreich K Wien Med Wochenschr; 1994; 144(17):407-11. PubMed ID: 7839688 [TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies and lipoprotein(a) in obese children. Pascut D; Princi T; Donato M; Tamaro G; Parco S Acta Paediatr; 2009 Apr; 98(4):703-7. PubMed ID: 19183123 [TBL] [Abstract][Full Text] [Related]
32. Lipoprotein apheresis in isolated hyperlipoproteinemia(a): a validated treatment or an illusion of validity? Berthold HK; Descamps OS; Gouni-Berthold I Eur J Clin Invest; 2013 Jan; 43(1):108-12. PubMed ID: 23190253 [No Abstract] [Full Text] [Related]
33. [The Evolution of Views on Lipoprotein(a): From Biomarker to the Therapeutic Target]. Safarova MS; Ezhov MV Kardiologiia; 2015; 55(4):71-82. PubMed ID: 26502507 [TBL] [Abstract][Full Text] [Related]